Sterile Manufacturing Expertise Coldstream Laboratories specializes in aseptic and non-aseptic drug product manufacturing, utilizing innovative mobile isolator technology within FDA-approved facilities. This positions them as a reliable partner for clients requiring high-containment manufacturing of potent, cytotoxic, and radiolabeled compounds.

Growth Through Acquisition Since being acquired by Piramal Pharma Solutions in 2015, Coldstream has benefited from strategic investment and integration into a global pharmaceutical manufacturing network, indicating potential for expansion and increased capacity to serve larger clients.

High-Quality Service Offerings The company provides comprehensive drug development services, including analytical chemistry, pre-formulation, and microbiology testing, presenting opportunities to upsell additional analytical and validation services to existing clients.

Market Positioning With revenue estimates between 25M and 50M and a specialized focus, Coldstream operates in a niche segment of the CDMO industry, competing with larger firms like WuXi and Lonza, and offering personalized and flexible services that can attract clients seeking customized manufacturing solutions.

Technological Capabilities The use of advanced manufacturing technology and a dedicated microbiology lab highlights Coldstream’s capacity for innovative, compliant, and reliable production processes, making it an attractive partner for companies looking to outsource complex sterile manufacturing tasks.